IRIS
CARRIERI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.504
AS - Asia 3.419
EU - Europa 2.934
SA - Sud America 835
AF - Africa 124
OC - Oceania 8
Totale 16.824
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.385
SG - Singapore 1.376
CN - Cina 791
BR - Brasile 681
DE - Germania 546
IT - Italia 503
SE - Svezia 407
HK - Hong Kong 383
RU - Federazione Russa 344
VN - Vietnam 303
FR - Francia 288
GB - Regno Unito 223
UA - Ucraina 171
FI - Finlandia 141
IN - India 122
BD - Bangladesh 64
ID - Indonesia 64
TR - Turchia 57
CA - Canada 48
AR - Argentina 47
IE - Irlanda 40
MX - Messico 39
NL - Olanda 39
JP - Giappone 38
IQ - Iraq 37
PL - Polonia 36
CI - Costa d'Avorio 35
BE - Belgio 33
AT - Austria 27
CO - Colombia 27
ES - Italia 24
ZA - Sudafrica 24
IR - Iran 22
PK - Pakistan 21
EC - Ecuador 19
SA - Arabia Saudita 18
CH - Svizzera 17
VE - Venezuela 17
CZ - Repubblica Ceca 16
PH - Filippine 16
UZ - Uzbekistan 16
CL - Cile 14
LT - Lituania 14
MY - Malesia 13
JO - Giordania 11
MA - Marocco 11
EG - Egitto 10
KE - Kenya 9
PY - Paraguay 9
DK - Danimarca 8
JM - Giamaica 8
DZ - Algeria 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
EE - Estonia 6
KR - Corea 6
PE - Perù 6
RO - Romania 6
TH - Thailandia 6
BO - Bolivia 5
CR - Costa Rica 5
KG - Kirghizistan 5
OM - Oman 5
RS - Serbia 5
BY - Bielorussia 4
GA - Gabon 4
GE - Georgia 4
LB - Libano 4
NG - Nigeria 4
NO - Norvegia 4
NP - Nepal 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
IL - Israele 3
LY - Libia 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SN - Senegal 2
Totale 16.802
Salva come PNG Salva come JPEG
Città #
Dallas 2.463
Fairfield 725
Singapore 725
Ashburn 699
Woodbridge 506
Chandler 505
San Jose 399
Houston 395
Hong Kong 368
Jacksonville 354
Nyköping 298
Seattle 287
Cambridge 251
Wilmington 239
Ann Arbor 222
Beijing 179
Bari 163
Lauterbourg 116
Nanjing 113
Lawrence 107
Roxbury 107
Los Angeles 103
Marseille 97
New York 97
Dong Ket 84
Ho Chi Minh City 80
Council Bluffs 76
Boardman 70
Brooklyn 64
Des Moines 64
Munich 59
Princeton 58
Hanoi 56
Santa Clara 56
São Paulo 52
London 46
Helsinki 44
San Diego 42
Jakarta 41
Dublin 37
Abidjan 35
Buffalo 35
Tokyo 33
Brussels 32
Jiaxing 32
North Bergen 32
Chicago 31
Inglewood 31
Frankfurt am Main 30
Milan 30
Nanchang 29
Warsaw 29
Amsterdam 27
Moscow 27
Orem 27
Chennai 25
Falkenstein 23
Rio de Janeiro 23
Shenyang 22
Nuremberg 21
Atlanta 20
Denver 20
Paris 20
Rome 20
Tianjin 19
Mumbai 18
Redwood City 18
San Francisco 18
Sannicandro di Bari 18
Guangzhou 17
Changsha 16
Dearborn 16
West Jordan 16
Belo Horizonte 15
Hebei 15
Istanbul 15
Boston 14
Montreal 14
Phoenix 14
Toronto 14
Johannesburg 13
Tashkent 13
Ankara 12
Brasília 12
Kansas City 12
Stockholm 12
Delhi 11
Leawood 11
Manchester 11
Medellín 11
Shanghai 11
Amman 10
Juiz de Fora 10
Mexico City 10
Redondo Beach 10
Wuhan 10
Baghdad 9
Boydton 9
Curitiba 9
Düsseldorf 9
Totale 11.573
Salva come PNG Salva come JPEG
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 1.117
1,3-Benzothiazoles as Antimicrobial Agents 1.091
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.089
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 233
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5- fluorobenzenethiol derivatives: Design, synthesis and in vitro antimicrobial screening 215
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 207
2-Aminobenzothiazole derivatives: Search for new antifungal agents 199
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones 198
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease 188
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 180
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 174
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II 163
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects 160
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 160
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 160
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 157
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 156
,3-Benzothiazoles as Antimicrobial Agents 155
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 153
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 153
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 148
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 148
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 142
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 137
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 136
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 136
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 136
High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones 134
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 133
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 133
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues. 127
3D-QSAR models and docking studies of reversible inhibitors of type A and B Monoamine Oxidases 125
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 123
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 123
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 123
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 120
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 119
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 119
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 116
The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models 115
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 114
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 113
Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study 113
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 113
Lubeluzole: from anti-ischemic to chemosensitizing agent 113
Evaluation of water‐soluble Mannich base prodrugs of 2,3,4,5‐tetrahydroazepino[4,3‐b]indol‐1(6H)‐one as multitarget‐directed agents for Alzheimer’s disease 113
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 112
Understanding of the MAO-A and B Reversible Inhibitory Activity and Selectivity by Using 3D Descriptors of Lipophilicity 111
alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 108
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist 108
Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with beta-cyclodextrins 108
Binding Models of Reversible Inhibitors to Monoamine Oxidases 107
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 106
Analisi conduttimetrica 106
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 105
Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. 105
Neuronal Nicotinic Agonists: a Multi-approach Development of the Pharmacophore 105
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 104
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. 103
Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists 101
Rational design of the new antihypertensive I1-receptor ligand 2-(2-biphenyl-2-yl-1-methyl-ethyl-)4,5-dihydro-1H-imidazole 99
High affinity central benzodiazepine receptor ligands II: QSAR studies and CoMFA analysis pyrazolo(4,3-c)quinolin-3-ones 97
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 95
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D-QSAR predictive models, 94
A twenty-year journey exploring coumarin-based derivatives as bioactive molecules 92
2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers 92
alfa2-adrenoreceptors profile modulation. 2.1 Biphenyline analogues as tools for selective activation of alfa2C-subtype 90
Binding models of reversible inhibitors to type-B monoamine oxidase 90
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 90
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 90
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders 90
Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus 89
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. 89
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 89
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 87
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 87
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 85
Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase 84
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils 84
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 84
Exploring the Antibiofilm Effect of Sertraline in Synergy with Cinnamomum verum Essential Oil to Counteract Candida Species 83
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D QSAR predictive models 83
Linezolid hybrid analogs: synthesis and antimicrobial studies of oxalodinone-mercaptobenzothiazole compounds 81
Recent Trends And Future Prospects In Computational GPCR Drug Discovery: From Virtual Screening To Polypharmacology. 81
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets 79
Modeling the structural basis of the human CCR5 chemokine receptor functions: from homology model-builiding and molecular dynamics validation to agonist and anatgonist docking 78
Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach 76
New molecular requirements of Toc derivatives bearing a novel class of Nav1.4 blockers 76
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults 75
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 74
SAR of Non-Nucleoside HIV-1 RT inhibitors (NNRTIs): Comparative Molecular field Analysis (CoMFA) and Docking Studies 74
N‑Aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels 74
Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents 72
Comparative Molecular Field Analysis of pyridawinone-containing alfa1-antagonists 72
Synthesis and Antimicrobial Activity of new-substitud-4H-1,4-benzothiazines 72
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 70
Multi-approach development of a new pharmacophore for neuronal nicotinic acetylcholine receptor agonists, 70
null 70
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 70
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 69
Totale 14.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 0 0 0 0 180 105 153
2021/2022851 43 105 11 41 22 48 49 44 56 84 134 214
2022/20231.556 220 141 93 125 183 190 14 155 337 22 40 36
2023/2024675 44 99 26 43 52 102 40 29 39 54 52 95
2024/20252.436 73 69 196 109 66 165 221 233 148 145 356 655
2025/20267.037 698 773 2.169 677 565 352 583 213 535 472 0 0
Totale 17.208